Nexrutine(®) preserves muscle mass similar to exercise in prostate cancer mouse model

Muscle loss is a debilitating side effect to prostate cancer (PCa) experienced by nearly 60% of men. The purpose of this study was to test the hypothesis that Nexrutine(®), a bark extract from the Phellodendrum amurense, can protect against prostate cancer induced muscle loss in a similar manner as...

Descripción completa

Detalles Bibliográficos
Autores principales: Patel, Darpan I., Wallace, Derek, Abuchowski, Kira, Rivas, Paul, Gallegos, Amber, Musi, Nicolas, Kumar, Addanki Pratap.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6712237/
https://www.ncbi.nlm.nih.gov/pubmed/31456341
http://dx.doi.org/10.14814/phy2.14217

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6712237/
https://www.ncbi.nlm.nih.gov/pubmed/31456341
http://dx.doi.org/10.14814/phy2.14217

Ejemplares similares